Accuray Incorporated's CEO to Speak at 31st Annual J.P. Morgan Healthcare Conference

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20121220:nPnSF33304

SUNNYVALE, Calif., Dec. 20, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq:
ARAY), the premier radiation oncology company, announced today that its
president and chief executive officer, Joshua H. Levine, is scheduled to
present at the J.P. Morgan Healthcare Conference in San Francisco on Monday,
January 7, 2013 at 9:00 a.m. PST/12:00 p.m. EST.

A live webcast of the presentations will be available online from the Investor
Relations page of the Company's website at http://www.accuray.com/investors.

The webcast replay of the presentation will begin approximately one hour after
the conclusion of the live presentation and will be available for approximately
30 days.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier
radiation oncology company that develops, manufactures and sells personalized,
innovative treatment solutions that set the standard of care with the aim of
helping patients live longer, better lives. The Company's leading-edge
technologies - the CyberKnife and TomoTherapy Systems - are designed to deliver
radiosurgery, stereotactic body radiation therapy, intensity modulated radiation
therapy, image guided radiation therapy, and adaptive radiation therapy. To
date, 667 systems have been installed in leading hospitals around the world. For
more information, please visit www.accuray.com.

SOURCE Accuray Incorporated

Investor Contact: Tom Rathjen, Vice President, Investor Relations,
+1-408-789-4458, trathjen@accuray.com, or Media Contact: Stephanie Tomei,
Director, Corporate Communications, +1-408-789-4234, stomei@accuray.com